I think the same thing, they should go to another cohort, hopefully at 600mg or higher. Not sure why Leo started talking about "options" after this cohort. I hope after cohort 10, they start two more 1) 600mg and 2) 450mg 2x week.
couple things to consider...on Feb 9th interview, Leo said cohort 10 to take approx 6 more weeks. That would put us at March 23.
I confirmed with Leo via email that cohort 10 patients (patients was plural, so at least two) have been dosed by Jan 30. and that the cohort is continuing (meaning 1 or less SAEs in that cohort by Jan 30). On Feb 9, the interview states "the 3 required patients": if there were any SAEs by then, he would not have said three, protocol requires them to increase to 6 total. Also, there was no mention of an SAE in the interview and no mention of an SAE in the 10Q (also provided on Feb. 9), so I believe another cohort with another increase is Likely. We should hear something with the next two weeks. The real question is: what do they do next?
Leo laid out three options - 1) cohort 11 with a dose increase 2) conclude trial 3) modify the protocol to increase dose frequency and target patients with specific cancers.
No they are not you liar. They are just posts on a message board. YOU ARE A TOTAL FRAUD. Everyone knows that...
He has got to be the dumbest investor I have ever seen on a message board. He gets it wrong every time. BIG TIME WRONG. But he always pick himself up, drops his pants, takes another pounding from behind and smiles afterwards ;-P
The company didn't send their typical PR two weeks before the earnings report. They have no good news to report. It certainly will tank tomorrow. They will have to do another 12:1 reverse split!